271 related articles for article (PubMed ID: 29215412)
1. Serial FDG-PET/CT Imaging in the Management of Cardiac Sarcoidosis.
Bremer W; Sweiss NJ; Lu Y
Clin Nucl Med; 2018 Feb; 43(2):e50-e52. PubMed ID: 29215412
[TBL] [Abstract][Full Text] [Related]
2. Serial FDG-PET scans help to identify steroid resistance in cardiac sarcoidosis.
Shelke AB; Aurangabadkar HU; Bradfield JS; Ali Z; Kumar KS; Narasimhan C
Int J Cardiol; 2017 Feb; 228():717-722. PubMed ID: 27886616
[TBL] [Abstract][Full Text] [Related]
3. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.
Blankstein R; Osborne M; Naya M; Waller A; Kim CK; Murthy VL; Kazemian P; Kwong RY; Tokuda M; Skali H; Padera R; Hainer J; Stevenson WG; Dorbala S; Di Carli MF
J Am Coll Cardiol; 2014 Feb; 63(4):329-36. PubMed ID: 24140661
[TBL] [Abstract][Full Text] [Related]
4. Suppression of Myocardial 18F-FDG Uptake Through Prolonged High-Fat, High-Protein, and Very-Low-Carbohydrate Diet Before FDG-PET/CT for Evaluation of Patients With Suspected Cardiac Sarcoidosis.
Lu Y; Grant C; Xie K; Sweiss NJ
Clin Nucl Med; 2017 Feb; 42(2):88-94. PubMed ID: 27922863
[TBL] [Abstract][Full Text] [Related]
5. Inter- and Intraobserver Agreement of
Ohira H; Ardle BM; deKemp RA; Nery P; Juneau D; Renaud JM; Klein R; Clarkin O; MacDonald K; Leung E; Nair G; Beanlands R; Birnie D
J Nucl Med; 2017 Aug; 58(8):1324-1329. PubMed ID: 28254873
[TBL] [Abstract][Full Text] [Related]
6. 11C-4DST PET/CT Imaging of Cardiac Sarcoidosis: Comparison With 18F-FDG and Cardiac MRI.
Hotta M; Minamimoto R; Kubota S; Awaya T; Hiroi Y
Clin Nucl Med; 2018 Jun; 43(6):458-459. PubMed ID: 29538030
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of heparin loading during an 18F-FDG PET/CT examination to search for cardiac sarcoidosis activity.
Ito K; Morooka M; Okazaki O; Minaminoto R; Kubota K; Hiroe M
Clin Nucl Med; 2013 Feb; 38(2):128-30. PubMed ID: 23334129
[TBL] [Abstract][Full Text] [Related]
8. Identification of cardiac sarcoidosis with (13)N-NH(3)/(18)F-FDG PET.
Yamagishi H; Shirai N; Takagi M; Yoshiyama M; Akioka K; Takeuchi K; Yoshikawa J
J Nucl Med; 2003 Jul; 44(7):1030-6. PubMed ID: 12843216
[TBL] [Abstract][Full Text] [Related]
9. The Utility of Whole Body
Giudicatti L; Marangou J; Nolan D; Dembo L; Baumwol J; Dwivedi G
Heart Lung Circ; 2020 Jan; 29(1):e1-e6. PubMed ID: 31501049
[TBL] [Abstract][Full Text] [Related]
10. Effect of Immunosuppressive Therapy and Biopsy Status in Monitoring Therapy Response in Suspected Cardiac Sarcoidosis.
Rojulpote C; Bhattaru A; Jean C; Adams SL; Patel V; Vidula MK; Selvaraj S; Dubroff J; Peyster E; Clancy CB; Patterson K; Marchlinski FE; Rossman M; Goldberg L; Bravo PE
JACC Cardiovasc Imaging; 2022 Nov; 15(11):1944-1955. PubMed ID: 36357136
[TBL] [Abstract][Full Text] [Related]
11. Monitoring the Therapy of Extensive Osseous Sarcoidosis With FDG PET/CT.
Yang H; Numani S; Liu S
Clin Nucl Med; 2017 Jul; 42(7):e337-e339. PubMed ID: 28240658
[TBL] [Abstract][Full Text] [Related]
12. Waxing and Waning Presentation of Isolated Cardiac Sarcoidosis on Sequential
Ostwani W; Hanna C; Brice AE; Wymer DC
J Nucl Med Technol; 2020 Dec; 48(4):378-380. PubMed ID: 32518122
[TBL] [Abstract][Full Text] [Related]
13. Elevated (18)F-fluorodeoxyglucose uptake in the interventricular septum is associated with atrioventricular block in patients with suspected cardiac involvement sarcoidosis.
Manabe O; Ohira H; Yoshinaga K; Sato T; Klaipetch A; Oyama-Manabe N; Ito YM; Tsujino I; Nishimura M; Tamaki N
Eur J Nucl Med Mol Imaging; 2013 Oct; 40(10):1558-66. PubMed ID: 23715906
[TBL] [Abstract][Full Text] [Related]
14. PET/CT Evaluation of Cardiac Sarcoidosis.
Bois JP; Muser D; Chareonthaitawee P
PET Clin; 2019 Apr; 14(2):223-232. PubMed ID: 30826020
[TBL] [Abstract][Full Text] [Related]
15. 68Ga-DOTATOC PET for Treatment Efficacy Evaluation of Cardiac Sarcoidosis.
Imperiale A; Poindron V; Martinez M; Ohlmann P; Schindler TH; El Ghannudi S
Clin Nucl Med; 2020 Sep; 45(9):e416-e418. PubMed ID: 32604122
[TBL] [Abstract][Full Text] [Related]
16. Spontaneous Reduction in Abnormal Myocardial Uptake of Fluorine-18 Fluorodeoxygluose in a Patient with Cardiac Sarcoidosis.
Terasaki F; Fujita SI; Kanzaki Y; Hirose Y; Ishizaka N
Int Heart J; 2018 May; 59(3):647-651. PubMed ID: 29681578
[TBL] [Abstract][Full Text] [Related]
17. FDG PET/CT Evidence of Effective Treatment of Cardiac Sarcoidosis With Adalimumab.
Miller CT; Sweiss NJ; Lu Y
Clin Nucl Med; 2016 May; 41(5):417-8. PubMed ID: 26828145
[TBL] [Abstract][Full Text] [Related]
18. Metabolism-perfusion imaging to predict disease activity in cardiac sarcoidosis.
Isiguzo M; Brunken R; Tchou P; Xu M; Culver DA
Sarcoidosis Vasc Diffuse Lung Dis; 2011 Jul; 28(1):50-5. PubMed ID: 21796891
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of myocardial 2-[18F]fluoro-2-deoxy-D-glucose uptake is a typical feature in cardiac sarcoidosis: a study of 231 patients.
Schildt JV; Loimaala AJ; Hippeläinen ET; Ahonen AA
Eur Heart J Cardiovasc Imaging; 2018 Mar; 19(3):293-298. PubMed ID: 28950301
[TBL] [Abstract][Full Text] [Related]
20. Extensive Biventricular Cardiac Sarcoidosis Detected on FDG PET/CT Using a 72-Hour Ketogenic Diet Preparation Protocol.
Lu Y
Clin Nucl Med; 2022 Aug; 47(8):728-729. PubMed ID: 35261354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
